AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2014
Jul 9, 2014
34931_dirs_2014-07-09_ab420faa-ca1f-42c3-8882-cf1a5dfdc8f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-07-08
Reporting Person: KLOSK STEVEN M (Director)